BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 7, 2018
View Archived Issues
Virpax signs license agreement to use LipoCure's liposome drug delivery technology
Read More
Microbiotica and Genentech enter strategic collaboration for IBD
Read More
FDA grants rare pediatric disease designation to CLR-131 for the treatment of rhabdomyosarcoma
Read More
Intra-Cellular initiates rolling submission of NDA for lumateperone
Read More
Moleculin Biotech enters agreement to develop formulation for its STAT3 inhibitor
Read More
Alkermes receives payment from Biogen related to BIIB-098 program
Read More
Effects on gut microbiome seen with Blautix in irritable bowel syndrome patients
Read More
S1P regulation key for bone quality and may constitute a therapeutic target in osteoporosis
Read More
Shandong Luoxin Pharmacy Group, Luoxin Biotechnology Shanghai Co. patent BRD4/1/2 inhibitors
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery identify HBV cccDNA inhibitors
Read More
New RORC modulators divulged by Bristol-Myers Squibb
Read More
Weishang Shanghai Bio-Pharmaceutical discovers mutant EGFR inhibitors
Read More
Merck & Co. synthesizes new FXIIa inhibitors
Read More
Dosing begins in phase II expansion portion of monotherapy trial of eFT-508 in non-GCB DLBCL
Read More
ROR-1-targeting cirmtuzumab inhibits stemness signatures in phase I trial in CLL patients
Read More
First healthy volunteers enrolled in phase I study of BTRX-335140
Read More
Positive results presented from ongoing phase I trial of PTI-801 in patients with CF
Read More
4D pharma and MSD collaborate to study Keytruda and MRx-0518 combination in solid tumors
Read More
FDA grants orphan drug designation to TransCon PTH
Read More
EMA grants PRIME designation for dilanubicel
Read More
Athersys expands its collaboration with Healios
Read More
Phase II results presented for TAK-954 in patients with enteral feeding intolerance
Read More
GlaxoSmithKline initiates phase I study of GSK-3858279
Read More
Enrollment ongoing in phase III study of pertuzumab and trastuzumab fixed-dose combination
Read More
Selinexor liposarcoma trial advances after improvement seen in progression-free survival
Read More